Screener
IMCB vs BBH
iShares Morningstar Mid-Cap ETF vs VanEck Biotech ETF
Key differences
Both IMCB and BBH are equity ETFs. IMCB charges 0.04% a year and BBH 0.35%. The main difference: IMCB costs 0.31% less per year.
- IMCB costs 0.31% less per year.
- IMCB is much larger than BBH. Larger funds are usually more liquid and less likely to close.
- Over the last three years, IMCB has delivered higher annualized returns.
- IMCB has a longer track record, which may reduce uncertainty around long-term behavior.
Side-by-side comparison
| IMCB | BBH | |
|---|---|---|
| Annual cost (TER) | 0.04% | 0.35% |
| Fund size (AUM) | $1.6B | $367M |
| Since | 2004 | 2011 |
| Dividend yield | 1.23% | 0.51% |
| Asset class | equity | equity |
| Region | north america | north america |
| Strategy | index tracking | index tracking |
| CAGR 1Y | +23.6% | +21.9% |
| CAGR 3Y | +17.5% | +6.6% |
| CAGR 5Y | +8.9% | -0.2% |
| Sharpe 3Y | 0.91 | 0.25 |
| Volatility 1Y | 13.25% | 19.41% |
| Max drawdown | -40.99% | -39.86% |
Beyond the comparison: Beacon helps you build, track, and project a portfolio with the ETFs you pick.